Back to search
FDAFDA · Food and drugs·Recall number F-0138-2014

Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

Published November 20, 2013 · Recall initiated: October 11, 2013

Summary

FDA records food Class II recall F-0138-2014, published November 20, 2013 and initiated October 11, 2013. Recalling firm: Metagenics, Inc.; Status: Terminated; Reported quantity: 1,171,300 units; Lot: Lot Code: 0413083 0513007 0513008. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Metagenics, Inc.
Distributor
Nationwide in US and worldwide to Japan, Taiwan, Belgium, and Canada
Lot
Lot Code: 0413083 0513007 0513008
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail. recalled?

Yes. FDA published recall F-0138-2014 on November 20, 2013. Reported hazard: Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail